In vivo targeting of inflammation-associated myeloid-related protein 8/14 via gadolinium immunonanoparticles

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 32, Issue 4, 2012, Pages 962-970

  Maiseyeu, Andrei ^a   Badgeley, Marcus A ^a   Kampfrath, Thomas ^a   Mihai, Georgeta ^a   Deiuliis, Jeffrey A ^a   Liu, Cuiqing ^a   Sun, Qinghua ^b   Parthasarathy, Sampath ^c   Simon, Daniel I ^d   Croce, Kevin ^e   Rajagopalan, Sanjay ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

atherosclerosis; imaging agents; macrophages; magnetic resonance imaging

Indexed keywords

ANTI MYELOID RELATED PROTEIN 14 NANOPARTICLE; ANTIINFLAMMATORY AGENT; APOLIPOPROTEIN E; CD11 ANTIGEN; CD11B ANTIGEN; CD31 ANTIGEN; GADOLINIUM; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOID RELATED PROTEIN 8; NANOPARTICLE; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR TARGETING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL WALL; BONE MARROW CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG CONJUGATION; DRUG SYNTHESIS; FLOW CYTOMETRY; IN VIVO STUDY; INFLAMMATION; MACROPHAGE; MALE; MOLECULARLY TARGETED THERAPY; MOUSE; MYELOID PROGENITOR CELL; NANOPROBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN TARGETING; WILD TYPE;

ALBUMINS; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIBODIES; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CALGRANULIN A; CALGRANULIN B; CELLS, CULTURED; CONTRAST MEDIA; CULTURE MEDIA, CONDITIONED; CYTOKINES; DISEASE MODELS, ANIMAL; FEASIBILITY STUDIES; FLOW CYTOMETRY; GADOLINIUM DTPA; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; IMMUNOCONJUGATES; INFLAMMATION; INFLAMMATION MEDIATORS; MACROPHAGES; MAGNETIC RESONANCE IMAGING; MALE; METAL NANOPARTICLES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID PROGENITOR CELLS; TISSUE DISTRIBUTION;

EID: 84862781849     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.111.244509     Document Type: Article

References (44)

1. Croce K, Gao H, Wang Y, Mooroka T, Sakuma M, Shi C, Sukhova GK, Packard RR, Hogg N, Libby P, Simon DI. Myeloid-related protein-8/14 is critical for the biological response to vascular injury. Circulation. 2009;120:427-436.
2. Healy AM, Pickard MD, Pradhan AD, Wang Y, Chen Z, Croce K, Sakuma M, Shi C, Zago AC, Garasic J, Damokosh AI, Dowie TL, Poisson L, Lillie J, Libby P, Ridker PM, Simon DI. Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events. Circulation. 2006;113:2278-2284. (Pubitemid 43947973)
3. Ostrand-Rosenberg S, Sinha P. Myeloid-derived suppressor cells: Linking inflammation and cancer. J Immunol. 2009;182:4499-4506.
4. Ryckman C, Vandal K, Rouleau P, Talbot M, Tessier PA. Proinflammatory activities of s100: proteins s100a8, s100a9, and s100a8/a9 induce neutrophil chemotaxis and adhesion. J Immunol. 2003;170:3233-3242. (Pubitemid 36302201)
5. Ionita MG, Vink A, Dijke IE, Laman JD, Peeters W, van der Kraak PH, Moll FL, de Vries JP, Pasterkamp G, de Kleijn DP. High levels of myeloid-related protein 14 in human atherosclerotic plaques correlate with the characteristics of rupture-prone lesions. ATVB. 2009;29: 1220-1227.
6. Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, Lu Y, Avila C, Kambham N, Bierhaus A, Nawroth P, Neurath MF, Slattery T, Beach D, McClary J, Nagashima M, Morser J, Stern D, Schmidt AM. Rage mediates a novel proinflammatory axis: a central cell surface receptor for s100/calgranulin polypeptides. Cell. 1999;97:889-901. (Pubitemid 29375048)
7. Morrow DA, Wang Y, Croce K, Sakuma M, Sabatine MS, Gao H, Pradhan AD, Healy AM, Buros J, McCabe CH, Libby P, Cannon CP, Braunwald E, Simon DI. Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the pravastatin or atorvastatin evaluation and infection therapy: Thrombolysis in myocardial infarction (prove it-timi 22) trial. American Heart Journal. 2008;155:49-55. (Pubitemid 350234770)
8. Rammes A, Roth J, Goebeler M, Klempt M, Hartmann M, Sorg C. Myeloid-related protein (mrp) 8 and mrp14, calcium-binding proteins of the s100 family, are secreted by activated monocytes via a novel, tubulindependent pathway. Journal of Biological Chemistry. 1997;272: 9496-9502. (Pubitemid 27154966)
9. Maiseyeu A, Mihai G, Roy S, Kherada N, Simonetti OP, Sen CK, Sun Q, Parthasarathy S, Rajagopalan S. Detection of macrophages via paramagnetic vesicles incorporating oxidatively tailored cholesterol ester: An approach for atherosclerosis imaging. Nanomedicine (Lond). 2010;5: 1341-1356.
10. Maiseyeu A, Mihai G, Kampfrath T, Simonetti OP, Sen CK, Roy S, Rajagopalan S, Parthasarathy S. Gadolinium-containing phosphatidylserine liposomes for molecular imaging of atherosclerosis. Journal of Lipid Research. 2009;50:2157-2163.
11. Harel-Adar T, Ben Mordechai T, Amsalem Y, Feinberg MS, Leor J, Cohen S. Modulation of cardiac macrophages by phosphatidylserinepresenting liposomes improves infarct repair. Proc Natl Acad Sci USA. 2011;108:1827-1832.
12. Kampfrath T, Maiseyeu A, Ying Z, Shah Z, Deiuliis JA, Xu X, Kherada N, Brook RD, Reddy KM, Padture NP, Parthasarathy S, Chen LC, Moffatt-Bruce S, Sun Q, Morawietz H, Rajagopalan S. Chronic fine particulate matter exposure induces systemic vascular dysfunction via NADPH oxidase and TLR4 pathways. Circulation Research. 2011;108: 716-726.
13. Robinson MJ, Tessier P, Poulsom R, Hogg N. The s100 family heterodimer, mrp-8/14, binds with high affinity to heparin and heparan sulfate glycosaminoglycans on endothelial cells. Journal of Biological Chemistry. 2002;277:3658-3665. (Pubitemid 34953239)
14. Averill MM, Barnhart S, Becker L, Li X, Heinecke JW, Leboeuf RC, Hamerman JA, Sorg C, Kerkhoff C, Bornfeldt KE. S100a9 differentially modifies phenotypic states of neutrophils, macrophages, and dendritic cells: implications for atherosclerosis and adipose tissue inflammation. Circulation. 2011;123:1216-1226.
15. Srikrishna G, Panneerselvam K, Westphal V, Abraham V, Varki A, Freeze HH. Two proteins modulating transendothelial migration of leukocytes recognize novel carboxylated glycans on endothelial cells. J Immunol. 2001;166:4678-4688. (Pubitemid 32233755)
16. Choudhury RP, Fisher EA. Molecular imaging in atherosclerosis, thrombosis, and vascular inflammation. ATVB. 2009;29:983-991.
17. Owen DR, Lindsay AC, Choudhury RP, Fayad ZA. Imaging of atherosclerosis. Annual Review of Medicine. 2011;62:25-40.
18. Ta HT, Prabhu S, Leitner E, Jia F, von Elverfeldt D, Jackson KE, Heidt T, Nair AK, Pearce H, von Zur Muhlen C, Wang X, Peter K, Hagemeyer CE. Enzymatic single-chain antibody tagging: A universal approach to targeted molecular imaging and cell homing in cardiovascular disease. Circulation Research. 2011;109:365-373.
19. McCarty OJ, Conley RB, Shentu W, Tormoen GW, Zha D, Xie A, Qi Y, Zhao Y, Carr C, Belcik T, Keene DR, de Groot PG, Lindner JR. Molecular imaging of activated von Willebrand factor to detect high-risk atherosclerotic phenotype. J Am Coll Cardiol Cardiovascular Imaging. 2010;3:947-955.
20. Frosch M, Strey A, Vogl T, Wulffraat NM, Kuis W, Sunderkotter C, Harms E, Sorg C, Roth J. Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis. Arthritis and Rheumatism. 2000;43:628-637. (Pubitemid 30394955)
21. Voganatsi A, Panyutich A, Miyasaki KT, Murthy RK. Mechanism of extracellular release of human neutrophil calprotectin complex. Journal of Leukocyte Biology. 2001;70:130-134. (Pubitemid 32613672)
22. Hirono K, Foell D, Xing Y, Miyagawa-Tomita S, Ye F, Ahlmann M, Vogl T, Futatani T, Rui C, Yu X, Watanabe K, Wanatabe S, Tsubata S, Uese K, Hashimoto I, Ichida F, Nakazawa M, Roth J, Miyawaki T. Expression of myeloid-related protein-8 and-14 in patients with acute kawasaki disease. J Am Coll Cardiol. 2006;48:1257-1264. (Pubitemid 44345126)
23. McCormick MM, Rahimi F, Bobryshev YV, Gaus K, Zreiqat H, Cai H, Lord RS, Geczy CL. S100a8 and s100a9 in human arterial wall. Implications for atherogenesis. Journal of Biological Chemistry. 2005;280: 41521-41529. (Pubitemid 41832213)
24. Nacken W, Sopalla C, Propper C, Sorg C, Kerkhoff C. Biochemical characterization of the murine s100a9 (mrp14) protein suggests that it is functionally equivalent to its human counterpart despite its low degree of sequence homology. European Journal of Biochemistry/FEBS. 2000;267: 560-565. (Pubitemid 30072915)
25. Ionita MG, Catanzariti LM, Bots ML, de Vries JP, Moll FL, Kwan Sze S, Pasterkamp G, de Kleijn DP. High myeloid-related protein: 8/14 levels are related to an increased risk of cardiovascular events after carotid endarterectomy. Stroke; A Journal of Cerebral Circulation. 2010;41: 2010-2015.
26. Loser K, Vogl T, Voskort M, Lueken A, Kupas V, Nacken W, Klenner L, Kuhn A, Foell D, Sorokin L, Luger TA, Roth J, Beissert S. The toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of autoreactive CD8+t cells. Nature Medicine. 2010;16:713-717.
27. Vogl T, Tenbrock K, Ludwig S, Leukert N, Ehrhardt C, van Zoelen MA, Nacken W, Foell D, van der Poll T, Sorg C, Roth J. Mrp8 and Mrp14 are endogenous activators of toll-like receptor 4, promoting lethal, endotoxininduced shock. Nature Medicine. 2007;13:1042-1049. (Pubitemid 47517513)
28. Kerkhoff C, Sorg C, Tandon NN, Nacken W. Interaction of S100A8/S100A9-arachidonic acid complexes with the scavenger receptor cd36 may facilitate fatty acid uptake by endothelial cells. Biochemistry. 2001; 40:241-248. (Pubitemid 32052697)
29. Wang Y, Sakuma M, Chen Z, Ustinov V, Shi C, Croce K, Zago AC, Lopez J, Andre P, Plow E, Simon DI. Leukocyte engagement of platelet glycoprotein Ibalpha via the integrin MAC-1 is critical for the biological response to vascular injury. Circulation. 2005;112:2993-3000. (Pubitemid 41612303)
30. Zago AC, Simon DI, Wang Y, Sakuma M, Chen Z, Croce K, Ustinov V, Shi C, Martinez Filho EE. The importance of the interaction between leukocyte integrin mac-1 and platelet glycoprotein IB-for leukocyte recruitment by platelets and for the inflammatory response to vascular injury. Arquivos Brasileiros de Cardiologia. 2008;90:54-63.
31. Hobbs JA, May R, Tanousis K, McNeill E, Mathies M, Gebhardt C, Henderson R, Robinson MJ, Hogg N. Myeloid cell function in Mrp-14 (S100A9) null mice. Molecular and Cellular Biology. 2003;23: 2564-2576. (Pubitemid 36351035)
32. Manitz MP, Horst B, Seeliger S, Strey A, Skryabin BV, Gunzer M, Frings W, Schonlau F, Roth J, Sorg C, Nacken W. Loss of s100a9 (Mrp14) results in reduced interleukin-8-induced cd11b surface expression, a polarized microfilament system, and diminished responsiveness to chemoattractants in vitro. Molecular and Cellular Biology. 2003;23: 1034-1043. (Pubitemid 36133519)
33. Choudhury RP, Fuster V, Badimon JJ, Fisher EA, Fayad ZA. MRI and characterization of atherosclerotic plaque: Emerging applications and molecular imaging. Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:1065-1074. (Pubitemid 34764854)
34. Libby P, Nahrendorf M, Weissleder R. Molecular imaging of atherosclerosis: A progress report. Texas Heart Institute Journal. 2010;37: 324-327.
35. van Schooneveld MM, Vucic E, Koole R, Zhou Y, Stocks J, Cormode DP, Tang CY, Gordon RE, Nicolay K, Meijerink A, Fayad ZA, Mulder WJ. Improved biocompatibility and pharmacokinetics of silica nanoparticles by means of a lipid coating: a multimodality investigation. Nano Letters. 2008;8:2517-2525.
36. Ravichandran KS, Lorenz U. Engulfment of apoptotic cells: signals for a good meal. Nature Reviews Immunology. 2007;7:964-974. (Pubitemid 350166061)
37. Podrez EA, Poliakov E, Shen Z, Zhang R, Deng Y, Sun M, Finton PJ, Shan L, Febbraio M, Hajjar DP, Silverstein RL, Hoff HF, Salomon RG, Hazen SL. A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor cd36 and is enriched in atherosclerotic lesions. Journal of Biological Chemistry. 2002;277:38517-38523. (Pubitemid 35154710)
38. Huynh ML, Fadok VA, Henson PM. Phosphatidylserine-dependent ingestion of apoptotic cells promotes tgf-beta1 secretion and the resolution of inflammation. Journal of Clinical Investigation. 2002;109: 41-50. (Pubitemid 34052540)
39. Hazen SL. Oxidized phospholipids as endogenous pattern recognition ligands in innate immunity. Journal of Biological Chemistry. 2008;283: 15527-15531.
40. Greenberg ME, Li XM, Gugiu BG, Gu X, Qin J, Salomon RG, Hazen SL. The lipid whisker model of the structure of oxidized cell membranes. Journal of Biological Chemistry. 2008;283:2385-2396.
41. Greenberg ME, Sun M, Zhang R, Febbraio M, Silverstein R, Hazen SL. Oxidized phosphatidylserine-cd36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cells. Journal of Experimental Medicine. 2006;203:2613-2625. (Pubitemid 44833338)
42. Ramos GC, Fernandes D, Charao CT, Souza DG, Teixeira MM, Assreuy J. Apoptotic mimicry: Phosphatidylserine liposomes reduce inflammation through activation of peroxisome proliferator-activated receptors (PPARS) in vivo. British Journal of Pharmacology. 2007;151:844-850. (Pubitemid 47075330)
43. Li AC, Glass CK. The macrophage foam cell as a target for therapeutic intervention. Nature Medicine. 2002;8:1235-1242. (Pubitemid 35373554)
44. Kuschert GS, Coulin F, Power CA, Proudfoot AE, Hubbard RE, Hoogewerf AJ, Wells TN. Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. Biochemistry. 1999;38:12959-12968.